Creating specialized polymers to improve drug delivery through the gut-blood barrier
Polyesters with controlled topologies for probing transcytosis at the gut-blood barrier
['FUNDING_R01'] · UNIVERSITY OF ALABAMA IN TUSCALOOSA · NIH-10925300
This study is exploring new tiny particles made from special materials that can help deliver medications more effectively when taken by mouth, aiming to improve how these treatments work in the body for people who need them.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ALABAMA IN TUSCALOOSA (nih funded) |
| Locations | 1 site (TUSCALOOSA, UNITED STATES) |
| Trial ID | NIH-10925300 on ClinicalTrials.gov |
What this research studies
This research focuses on developing new types of polymer nanoparticles that can effectively deliver medications when taken orally. It addresses two main challenges: the need for versatile polymer structures that can customize drug delivery and the lack of tools to predict how these drug-laden nanoparticles behave in the body. By conducting various laboratory and animal tests, the researchers aim to gain insights into how these polymers are absorbed and processed in the body. The ultimate goal is to create a mathematical model that can help translate these findings from preclinical studies to clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who require medications that are typically difficult to deliver effectively through oral routes.
Not a fit: Patients who do not take medications orally or have conditions that require alternative delivery methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective oral drug delivery systems, improving treatment options for patients.
How similar studies have performed: Previous research has shown promise in using polymer nanoparticles for drug delivery, indicating that this approach has potential for success.
Where this research is happening
TUSCALOOSA, UNITED STATES
- UNIVERSITY OF ALABAMA IN TUSCALOOSA — TUSCALOOSA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MAJETI, RAVIKUMAR N — UNIVERSITY OF ALABAMA IN TUSCALOOSA
- Study coordinator: MAJETI, RAVIKUMAR N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.